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Abstract Ca2+ uptake by brain mitochondria induces the
release of up to 40% of total cytochrome c in a cyclosporin A-
insensitive manner. In the presence of ATP and Mg2+, this
process is not accompanied by mitochondrial swelling. There is a
moderate decrease in membrane potential under these conditions,
but it is completely reversible upon removal of accumulated Ca2+
by addition of EGTA+A23187 but not by EGTA alone. These
observations provide evidence that cytochrome c release from
brain mitochondria does not require the membrane permeability
transition. However, brain mitochondria can undergo the
permeability transition in the absence of ATP and Mg2+, which
results in cyclosporin A-sensitive large amplitude swelling, loss of
Ca2+ uptake capacity and release of matrix solutes.
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1. Introduction
In various apoptotic cell death paradigms, release of mito-
chondrial cytochrome c into the cytosol is a key step linking
the triggering phase of apoptosis to the executioning phase
[1^3]. This process is widely regarded as mediated by the onset
of the mitochondrial permeability transition [4,5], a complex
phenomenon in which mitochondria uniformly respond to
di¡erent challenges by opening a Ca2-dependent, cyclosporin
A-sensitive inner membrane pore non-selectively permeable to
solutes of MW up to 1500 [6]. In experiments with isolated
mitochondria, pore opening leads to mitochondrial membrane
depolarization, equilibration of ions and other low MW so-
lutes across membranes, and large amplitude swelling due to
the osmotic pressure of large MW mitochondrial matrix poly-
mers.
The pathway by which cytochrome c leaves its normal lo-
cation in the intermembrane space proposed independently by
Skulachev [7] and Kroemer and co-authors [8] is based upon
the above mechanism. It is known that large amplitude swell-
ing in saline media causes reversible respiratory inhibition due
to cytochrome c loss as a result of outer membrane rupture
[9]. Several di¡erent laboratories have demonstrated that the
permeability transition induced by various triggers leads to
swelling and cytochrome c release from liver mitochondria
[10^13].
An alternative mechanism was proposed to explain cell
death experiments in which cytochrome c release occurs be-
fore or independently of mitochondrial depolarization
[3,14,15]. This mechanism involves release of cytochrome c
through an outer membrane pore or channel that does not
require the mitochondrial permeability transition or mito-
chondrial swelling.
Unlike mitochondria isolated from many other tissues, e.g.
liver, brain can accumulate very little Ca2 in the absence of
adenine nucleotides [16,17]. On the other hand, brain mito-
chondria are less prone to undergo the permeability transi-
tion-mediated swelling than liver mitochondria [18,19]. Con-
sidering the increasing evidence that brain mitochondrial Ca2
uptake is involved in both bu¡ering normal elevations in in-
traneuronal Ca2 [20,21] and mediating both necrotic and
apoptotic death caused by excitotoxic neurotransmitters
[22^25], the objective of this study was to determine the rela-
tionship between Ca2 uptake and cytochrome c release in
brain mitochondria and to determine what role, if any, the
permeability transition plays in this process.
2. Materials and methods
Rat brain mitochondria were isolated according to the procedure of
Rosenthal et al. [26] yielding non-synaptosomal plus synaptosomal
mitochondria. Mitochondrial protein was determined by a modi¢ed
biuret reaction [27]. Mitochondria were incubated at 37‡C in media
containing 125 mM KCl, 2 mM K2HPO4, 5 mM HEPES-KOH (pH
7.0) and supplemented with respiratory substrates, 3 mM ATP and
4 mM MgCl2 as indicated. Ca2 £uxes were monitored £uorometri-
cally with calcium green 5N (0.1 WM). Light scattering of the mito-
chondrial suspension was measured at a right angle with a Perkin-
Elmer LS-3 £uorescence spectrometer at 520 nm or alternatively
as absorbance at 660 nm. Mitochondrial membrane potential was
monitored using a TPP-selective electrode and 2 WM TPP-Cl.
For measurements of mitochondrial cytochrome c, glutathione or
Quin-2 release, an aliquot of the experimental suspension was centri-
fuged at 13 000Ug for 2 min. An 0.75 ml aliquot of supernatant was
carefully removed and used for the assays or supplemented with 15 Wl
of Protease Inhibitor Cocktail (Sigma), frozen on dry ice and stored at
370‡C. The pellet was resuspended in 1 ml of the medium and stored
likewise. For cytochrome c immunoblots, 16 Wl aliquots of the sam-
ples (diluted to 0.12 mg mitochondrial protein/ml for the pellets) were
run on to 4^20% Tris-glycine gradient gels. Proteins were electrotrans-
ferred to PVDF membranes, membranes were rinsed with TBS-T
bu¡er and blocked overnight in TBS-T supplemented with 10% dry
milk. Cytochrome c was immunostained with primary 7H8 mouse
anti-cytochrome c antibody (PharMingen) plus secondary anti-mouse
Ig bound to horseradish peroxidase (Amersham) (1:2000 dilution
each). Peroxidase activity was detected using the Enhanced Chemilu-
minescence detection kit (Amersham) and X-ray ¢lm. Band intensities
were analyzed densitometrically using GelExpert system (Nucleo-
Tech). Glutathione in the supernatant samples was measured in enzy-
matic recycling assay [28]. For measurements of permeability to Quin-
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2, mitochondria were preloaded by incubating with 100 WM Quin-
2AM for 1 h at 37‡C in the dark. Following the experimental incu-
bation, Quin-2 was measured in the supernatant sample £uorometri-
cally.
3. Results and discussion
3.1. Rat brain mitochondria do not undergo Ca2+-induced
permeability transition in the presence of ATP and Mg2+
Rat brain mitochondria incubated in physiologically rele-
vant KCl-based medium in the presence of ATP and Mg2
rapidly accumulate added Ca2 up to approximately 4 Wmol/
mg of protein (data not shown). Ca2 uptake is associated
with the normal transient drop in mitochondrial membrane
potential (Fig. 1A) which, however, is not followed by spon-
taneous complete depolarization typical of the permeability
transition. Moreover, instead of this process being accompa-
nied by the classical large amplitude swelling resulting in de-
crease in light scattering, Ca2 uptake leads to a light scatter-
ing increase (Fig. 1B). Neither the membrane potential nor the
light scattering changes are sensitive to cyclosporin A (data
not shown).
The decrease in membrane potential observed upon the
completion of Ca2 uptake is completely reversible when
Ca2 is sequestered with the Ca2 chelator EGTA plus the
Ca2 ionophore A23187 (Fig. 1A). This e¡ect is not observed
upon addition of EGTA alone, indicating that the mitochon-
dria remain impermeable to Ca2 and EGTA. We hypothesize
that Ca2-induced decrease in membrane potential is due to
the moderate and reversible respiratory inhibition observed
under these conditions (data not shown).
Further experiments indicated that the Ca2-induced in-
crease in brain mitochondrial light scattering results from
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Fig. 1. Brain mitochondria do not undergo the permeability transi-
tion in the presence of ATP and Mg2. Membrane potential (A)
and absorbance at 660 nm (B) are shown. See Section 2 for condi-
tions; 5 mM succinate in the presence of 2 WM rotenone was used
as respiratory substrate. Additions: Mito: 0.5 mg mitochondrial
protein/ml; Ca: 2.1 Wmol CaCl2/mg protein; EGTA: 2 mM;
A23187: 0.4 Wg/ml; Alm: 40 Wg alamethicin/mg protein.
Fig. 2. Light scattering changes in suspensions of brain mitochon-
dria in the presence or absence of ATP and Mg2. See Section 2
for conditions; 5 mM glutamate plus 5 mM malate were used as
respiratory substrates. A: Ca2-induced light scattering increase in
the presence of ATP and Mg2 at di¡erent concentrations of mito-
chondria. Additions: Mito: 0.25 mg mitochondrial protein/ml (a^c)
or 0.12 mg/ml (d, e); Ca: 0 (c), 260 (b, e), 400 (d) or 525 (a) WM
CaCl2. Numbers in parentheses show ratios of v light scattering/
[Ca2]. B: Ca2 dose dependence of v light scattering changes (v)
in the presence (a) or absence (b) of ATP and Mg2. Dotted line
shows the level of light scattering changes upon permeabilization
with alamethicin.
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Ca2 precipitation in the matrix rather than mitochondrial
shrinkage. The increase in light scattering that can be ob-
served in highly hypertonic medium (550 mosM) is much
smaller than what is observed following Ca2 accumulation
(data not shown). Ca2 accumulation also leads to an increase
in light scattering proportional to the amount of Ca2 added
over a wide concentration range (Fig. 2B, curve a) that is
approximately the same at both 0.25 and 0.12 mg mitochon-
drial protein/ml (Fig. 2A). As the change in light scattering is
dependent on the total Ca2 accumulated rather than on the
amount taken up per mg mitochondrial protein, the increase
in scattering seen in these experiments is likely due to the
formation of calcium phosphate-based precipitates, as has
been previously described [29,30].
The increase in light scattering observed in the presence of
ATP and Mg2 could, but does not obscure a signi¢cant
decrease in light scattering due to swelling. As shown in
Fig. 1B, the light scattering changes are completely reversible
by releasing accumulated Ca2 with EGTA and A23187. The
same complete reversibility is observed by eliminating the
membrane potential with the addition of a protonophoric
uncoupler (0.5 WM FCCP) which normally causes a net de-
crease in light scattering in liver mitochondria by promoting
the permeability transition (data not shown) [31,32].
3.2. Brain mitochondria are capable of Ca2+-induced
permeability transition in the absence of ATP and Mg2+
The ability of brain mitochondria to undergo the perme-
ability transition under any circumstances is questionable [17^
19]. We therefore performed experiments in the absence of
ATP and Mg2, which are known to inhibit the transition
in liver mitochondria [33,34]. In the absence of ATP and
Mg2 only a small fraction of an addition of 1.6 Wmol
Ca2/mg is accumulated by isolated brain mitochondria
(Fig. 3A). However, in the presence of inhibitors of the per-
meability transition (i.e. cyclosporin A or butylated hydroxy-
toluene (BHT)) (Fig. 3A), all of the added Ca2 was accumu-
lated. A similar protective e¡ect on Ca2 accumulation is
observed in the presence of 15^30 WM ADP in the presence
of oligomycin (data not shown), which is also known to in-
hibit the permeability transition [33].
The severe reduction in Ca2 uptake capacity observed with
brain mitochondria in the absence of ATP and Mg2 is ac-
companied by large amplitude swelling (i.e. a decrease in light
scattering) upon addition of Ca2 (Fig. 3B). This e¡ect is also
sensitive to cyclosporin A (Fig. 3B). The extent of swelling is
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Fig. 3. Brain mitochondria are capable of the permeability transi-
tion in the absence of ATP and Mg2. Calcium uptake (A) and
light scattering (B) are shown. See Section 2 for conditions; 5 mM
succinate in the presence of 2 WM rotenone was used as respiratory
substrate. Additions: Mito: 0.25 mg mitochondrial protein/ml; Ca:
1.6 Wmol CaCl2/mg protein (A) or 0.8 Wmol/mg (B); CsA: 0.5 WM
cyclosporin A; BHT: 50 WM butylated hydroxytoluene; Alm: 40 Wg
alamethicin/mg protein. Mitochondrial samples collected at the end
of the experimental period (A) were used for immunoblots shown in
Fig. 4D.
Fig. 4. Cytochrome c release from brain mitochondria in the pres-
ence (A^C) or absence (D) of ATP and Mg2. Representative re-
sults are presented for supernatants (s) and pellets (p). Each panel
represents results from an individual immunoblot. See Section 2 for
conditions of incubations; 5 mM glutamate plus 5 mM malate (A^
C) or 5 mM succinate in the presence of 2 WM rotenone (D) were
used as respiratory substrates. Control: incubation without addi-
tions; Ca: 3.2 Wmol CaCl2/mg protein (A, B) or 1.6 Wmol/mg (D);
DNP: 90 WM dinitrophenol; CsA: 0.5 WM cyclosporin A; RR:
0.2 WM ruthenium red; BHT: 50 WM butylated hydroxytoluene.
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substantially lower than the maximal swelling obtained upon
permeabilization of the mitochondria with the arti¢cial pore-
forming compound alamethicin (Fig. 3B; Fig. 2B, curve b).
These results suggest that only a fraction of the mitochondrial
population undergoes permeabilization under these condi-
tions. This observation may relate to the fact that the
heterogeneous mitochondrial preparation used in these studies
contains both synaptosomal and non-synaptosomal mito-
chondria.
Additional evidence that brain mitochondria can undergo a
permeability transition was obtained by measuring Ca2-in-
duced release of matrix solutes into the incubation medium.
Ca2-induced release of matrix glutathione reaches 1.0 nmol/
mg protein compared to 1.3 nmol/mg protein elicited by ala-
methicin. The Ca2-induced release is inhibited by cyclosporin
A (to the level of 0.1 nmol/mg protein). Ca2 also induces the
release of up to 70% of Quin-2 from preloaded mitochondria.
Therefore, in the absence of ATP and Mg2, brain mitochon-
dria can undergo the permeability transition, but the extent of
the transition and particularly the extent of swelling is reduced
compared to what has been reported for liver mitochondria.
Most importantly, in the presence of ATP and Mg2, brain
mitochondria do not undergo the transition even at extremely
high levels of Ca2.
3.3. Cytochrome c release from brain mitochondria occurs
independently of the permeability transition
When brain mitochondria are incubated for 10 min in the
presence or absence of ATP and Mg2 but in the absence of
added Ca2 and then centrifuged, cytochrome c is associated
mainly with the mitochondrial pellet. Background cytochrome
c release into the medium supernatant is only 3^5% of the
total (Fig. 4A,D). Addition of Ca2 causes release of cyto-
chrome c both in the presence and in the absence of ATP and
Mg2 (Fig. 4A,B,D). In the presence of ATP and Mg2, this
release reaches a maximum of approximately 40% of the total
at 0.3^0.7 Wmol/mg protein and does not increase at higher
levels of Ca2 (Fig. 4C), despite the fact that the maximal
Ca2 uptake capacity exceeds 4 Wmol/mg.
The release of cytochrome c is blocked by ruthenium red,
an inhibitor of the Ca2 uptake uniporter (Fig. 4B). The
mechanism of Ca2 uptake-stimulated cytochrome c release
is not simply the consequence of the membrane depolarization
that accompanies Ca2 uptake since depolarization of the
mitochondrial membrane with the uncoupler DNP does not
evoke release (Fig. 4A).
Cyclosporin A does not inhibit Ca2-stimulated release of
cytochrome c from brain mitochondria in the presence of
ATP and Mg2 (Fig. 4B). Moreover, neither cyclosporin A
nor BHT inhibits cytochrome c release in the absence of ATP
and Mg2 (Fig. 4D), even though they do inhibit the mem-
brane permeability transition under these conditions (Fig. 3).
The ¢ndings that cyclosporin A had no e¡ect on release under
conditions where it does inhibit the permeability transition,
and that the amount of cytochrome c release under these
conditions is not greater than when the permeability is sup-
pressed by ATP and Mg2 are surprising. These ¢ndings
could be interpreted as due to the presence of a fraction of
brain mitochondria that do not undergo the permeability
transition. Alternatively, unlike liver mitochondria, Ca2-
evoked swelling of brain mitochondria may be insu⁄cient to
disrupt the mitochondrial outer membrane. As membrane dis-
ruption is not necessarily responsible for Ca2-induced cyto-
chrome c release by brain mitochondria, studies are in prog-
ress to assess the possible roles of outer membrane pores in
this process.
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